Ignite Creation Date:
2025-12-25 @ 1:18 AM
Ignite Modification Date:
2026-02-20 @ 10:57 PM
Study NCT ID:
NCT04331093
Status:
RECRUITING
Last Update Posted:
2021-05-26
First Post:
2020-03-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma
Sponsor:
Organization: